The effect of quercetin supplementation on clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.

ABSTRACT: Coronavirus disease (COVID-19) affects both the respiratory system and the body as a whole. Natural molecules, such as flavonoid quercetin, as potential treatment methods to help patients combat COVID-19. The aim of this systematic review and meta-analysis is to give a comprehensive overview of the impact of quercetin supplementation on inflammatory factors, hospital admission, and mortality of patients with COVID-19. The search has been conducted on PubMed, Scopus, Web of Science, EMBASE, and the Cochrane Library using relevant keywords until August 25, 2023. We included randomized controlled trials (RCTs) comparing COVID-19 patients who received quercetin supplementation versus controls. We included five studies summarizing the evidence in 544 patients. Meta-analysis showed that querceti

SUBMITTER: Ziaei S 

PROVIDER: S-EPMC10724618 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature